AFAP1-AS1 (lncRNA) is transferred to breast cancer cells after being encapsulated by exosomes, leading to up-regulation of HER-2 expression and induction of trastuzumab resistance in BCCs by promoting AUF1-mediated ERBB2 translation activation [84]. Here, ERBB2 is linked to breast carcinoma.